Financial Consulate’s SELLAS Life Sciences SLS Stock Holding History

Financial Consulate’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.86K	Hold	600	–	–	﹤0.01%	703
2026 Q1	$2.54K	Buy	+600	New	+$2.68K	﹤0.01%	935

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Financial Consulate's SLS Position: Q2 2026 in Review

Financial Consulate held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 600 shares worth $8.86K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Financial Consulate first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

Financial Consulate held 600 shares of SELLAS Life Sciences worth $8.86K as of Q2 2026.
Financial Consulate left its SELLAS Life Sciences share count unchanged in Q2 2026.
SELLAS Life Sciences made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #703 holding.
Financial Consulate first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.